Puma Biotechnology Announces Underwriters’ Full Exercise of Option to Purchase Additional Shares

[Business Wire] – Puma Biotechnology, Inc. , a development stage biopharmaceutical company, announced that the underwriters for its public offering of 979,592 shares of its common stock at $122.50 per share have elected to exercise in full their option t more

View todays social media effects on PBYI

View the latest stocks trending across Twitter. Click to view dashboard

See who Puma is hiring next, click here to view